Papachristou DN, Agnanti N, D’Agostino H, Fortner JG. Histologically positive esophageal margin in the surgical treatment of gastric cancer. Am J Surg 1980; 139: 711-713.
Hockey MS, Fielding JWL, Kelly KA, et al. for the British Stomach Cancer Group. Resection line disease in stomach cancer. Br Med J 1984; 289: 601-603.
Songun I, Bonenkamp JJ, Hermans J, et al. Prognostic value of resection-line involvement in patients undergoing curative resections for gastric cancer. Eur J Cancer 1996; 32A: 433-437.
Kim SH, Karpeh MS, Klimstra DS, Leang D, Brennan MF. Effect of microscopic resection line disease on gastric cancer survival. J Gastrointest Surg 1999; 3: 2433.
Cascinu S, Giordani P, Catalano V, Agostinelli R, Catalano G. Resection-line involvement in gastric cancer patients undergoing curative resections: Implications for clinical management. Jap J Clin Oncol 1999; 29: 291-293.
Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma -2nd English edition-. Gastric Cancer 1998; 1: 10-24.
Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
White RR, Mackie JA, Fitts WT. An analysis of twenty years’ experience with operations for carcinoma of the stomach. Ann Surg 1975; 181: 611-614.
Schrock TR, Way LW. Total gastrectomy. Am J Surg 1978; 135: 348-355.
Bizer LS. Adenocarcinoma of the stomach. Current results of treatment. Cancer 1983; 51: 743-745.
Blomjous JGAM, Hop WCJ, Langenhorst LAM, ten Kate FJW, Eykenboom WMH, Tilanus HW. Adenocarcinoma of the gastric cardia: Recurrence and survival after resection. Cancer 1992; 70: 569-574.
Hallissey MT, Jewkes AJ, Dunn JA, Fielding JWL. Resection-line involvement in gastric cancer: A continuing problem. Br J Surg 1993; 80: 1418-1420.
Chan WH, Wong WK, Khin LW, Chan HS, Soo KC. Significance of a positive oesophageal margin in stomach cancer. Aust NZJ Surg 2000; 70: 700-703.
Ersan Y, Yavuz N, Kuflaslan R, ve ark. Potansiyel olarak küratif rezeksiyon geçiren mide kanseri hastalar›nda mikroskopik rezeksiyon s›n›r› tutulmas›n›n erken ve geç sonuçlar›. Cerrahpafla T›p Dergisi 2005; 36: 12-19.
Zacho A, Cederqvist C, Fischerman K. Surgical treatment of gastric malignancies: A twenty-year series comprising mainly far advanced and high-seated tumors. Ann Surg 1974; 179: 94-101.
Kim J-P, Kwon OJ, Oh ST, Yang HK. Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann Surg 1992; 216: 269-278.
Smith JW, Brennan MF. Surgical treatment of gastric cancer. Surg Clin N Am 1992; 72: 381-399.
Munson JL, O’Mahony R. Radical gastrectomy for cancer of the stomach. Surg Clin N Am 2005; 85: 1021-1032.
Bozzetti F, Bonfanti G, Bufalino R, et al. Adequacy of margins of resection in gastrectomy for cancer. Ann Surg 1982; 196: 685-690.
Bozzetti F, Marubini E, Bonfanti G, et al. Total versus subtotal gastrectomy: Surgical morbidity and mortality rates in a multicenter Italian randomized trial. Ann Surg 1997; 226: 613-620.
Keighley MRB, Moore J, Lee JR, Malins D, Thompson H. Peroperative frozen section and cytology to assess proximal invasion in gastro-oesophageal carcinoma. Br J Surg 1981; 68: 73-74.
Nakamura K, Ueyama T, Yao T, et al. Pathology and prognosis of gastric carcinoma: Findings in 10,000 patients who underwent primary gastrectomy. Cancer 1992; 70: 1030-1037.
Tsujitani S, Okuyama T, Orita H, et al. Margins of resection of the esophagus for gastric cancer with esophageal invasion. Hepatogastroenterology 1995; 42: 873-877.
Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R. Cancer of stomach: A patient care study by the American College of Surgeons. Ann Surg 1993; 218: 583-592.
Shiu MH, Perrotti M, Brennan MF. Adenocarcinoma of the stomach: A multivariate analysis of clinical, pathologic and treatment factors. Hepatogastroenterology 1989; 36: 7-12.
Sano T, Mudan SS. No advantage of reoperation for positive resection margins in node positive gastric cancer patients? Jap J Clin Oncol 1999; 29: 283-284.
Year 2009,
Volume: 40 Issue: 2, 45 - 52, 15.11.2013
Papachristou DN, Agnanti N, D’Agostino H, Fortner JG. Histologically positive esophageal margin in the surgical treatment of gastric cancer. Am J Surg 1980; 139: 711-713.
Hockey MS, Fielding JWL, Kelly KA, et al. for the British Stomach Cancer Group. Resection line disease in stomach cancer. Br Med J 1984; 289: 601-603.
Songun I, Bonenkamp JJ, Hermans J, et al. Prognostic value of resection-line involvement in patients undergoing curative resections for gastric cancer. Eur J Cancer 1996; 32A: 433-437.
Kim SH, Karpeh MS, Klimstra DS, Leang D, Brennan MF. Effect of microscopic resection line disease on gastric cancer survival. J Gastrointest Surg 1999; 3: 2433.
Cascinu S, Giordani P, Catalano V, Agostinelli R, Catalano G. Resection-line involvement in gastric cancer patients undergoing curative resections: Implications for clinical management. Jap J Clin Oncol 1999; 29: 291-293.
Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma -2nd English edition-. Gastric Cancer 1998; 1: 10-24.
Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
White RR, Mackie JA, Fitts WT. An analysis of twenty years’ experience with operations for carcinoma of the stomach. Ann Surg 1975; 181: 611-614.
Schrock TR, Way LW. Total gastrectomy. Am J Surg 1978; 135: 348-355.
Bizer LS. Adenocarcinoma of the stomach. Current results of treatment. Cancer 1983; 51: 743-745.
Blomjous JGAM, Hop WCJ, Langenhorst LAM, ten Kate FJW, Eykenboom WMH, Tilanus HW. Adenocarcinoma of the gastric cardia: Recurrence and survival after resection. Cancer 1992; 70: 569-574.
Hallissey MT, Jewkes AJ, Dunn JA, Fielding JWL. Resection-line involvement in gastric cancer: A continuing problem. Br J Surg 1993; 80: 1418-1420.
Chan WH, Wong WK, Khin LW, Chan HS, Soo KC. Significance of a positive oesophageal margin in stomach cancer. Aust NZJ Surg 2000; 70: 700-703.
Ersan Y, Yavuz N, Kuflaslan R, ve ark. Potansiyel olarak küratif rezeksiyon geçiren mide kanseri hastalar›nda mikroskopik rezeksiyon s›n›r› tutulmas›n›n erken ve geç sonuçlar›. Cerrahpafla T›p Dergisi 2005; 36: 12-19.
Zacho A, Cederqvist C, Fischerman K. Surgical treatment of gastric malignancies: A twenty-year series comprising mainly far advanced and high-seated tumors. Ann Surg 1974; 179: 94-101.
Kim J-P, Kwon OJ, Oh ST, Yang HK. Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann Surg 1992; 216: 269-278.
Smith JW, Brennan MF. Surgical treatment of gastric cancer. Surg Clin N Am 1992; 72: 381-399.
Munson JL, O’Mahony R. Radical gastrectomy for cancer of the stomach. Surg Clin N Am 2005; 85: 1021-1032.
Bozzetti F, Bonfanti G, Bufalino R, et al. Adequacy of margins of resection in gastrectomy for cancer. Ann Surg 1982; 196: 685-690.
Bozzetti F, Marubini E, Bonfanti G, et al. Total versus subtotal gastrectomy: Surgical morbidity and mortality rates in a multicenter Italian randomized trial. Ann Surg 1997; 226: 613-620.
Keighley MRB, Moore J, Lee JR, Malins D, Thompson H. Peroperative frozen section and cytology to assess proximal invasion in gastro-oesophageal carcinoma. Br J Surg 1981; 68: 73-74.
Nakamura K, Ueyama T, Yao T, et al. Pathology and prognosis of gastric carcinoma: Findings in 10,000 patients who underwent primary gastrectomy. Cancer 1992; 70: 1030-1037.
Tsujitani S, Okuyama T, Orita H, et al. Margins of resection of the esophagus for gastric cancer with esophageal invasion. Hepatogastroenterology 1995; 42: 873-877.
Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R. Cancer of stomach: A patient care study by the American College of Surgeons. Ann Surg 1993; 218: 583-592.
Shiu MH, Perrotti M, Brennan MF. Adenocarcinoma of the stomach: A multivariate analysis of clinical, pathologic and treatment factors. Hepatogastroenterology 1989; 36: 7-12.
Sano T, Mudan SS. No advantage of reoperation for positive resection margins in node positive gastric cancer patients? Jap J Clin Oncol 1999; 29: 283-284.
Duraker, N. (2013). Mide Karsinomalı Hastalarda Mikroskopik Rezeksiyon Sınırı Tutulumunun Prognostik Önemi. Cerrahpaşa Tıp Dergisi, 40(2), 45-52.
AMA
Duraker N. Mide Karsinomalı Hastalarda Mikroskopik Rezeksiyon Sınırı Tutulumunun Prognostik Önemi. Cerrahpaşa Tıp Dergisi. November 2013;40(2):45-52.
Chicago
Duraker, Nüvit. “Mide Karsinomalı Hastalarda Mikroskopik Rezeksiyon Sınırı Tutulumunun Prognostik Önemi”. Cerrahpaşa Tıp Dergisi 40, no. 2 (November 2013): 45-52.
EndNote
Duraker N (November 1, 2013) Mide Karsinomalı Hastalarda Mikroskopik Rezeksiyon Sınırı Tutulumunun Prognostik Önemi. Cerrahpaşa Tıp Dergisi 40 2 45–52.
IEEE
N. Duraker, “Mide Karsinomalı Hastalarda Mikroskopik Rezeksiyon Sınırı Tutulumunun Prognostik Önemi”, Cerrahpaşa Tıp Dergisi, vol. 40, no. 2, pp. 45–52, 2013.
ISNAD
Duraker, Nüvit. “Mide Karsinomalı Hastalarda Mikroskopik Rezeksiyon Sınırı Tutulumunun Prognostik Önemi”. Cerrahpaşa Tıp Dergisi 40/2 (November 2013), 45-52.
JAMA
Duraker N. Mide Karsinomalı Hastalarda Mikroskopik Rezeksiyon Sınırı Tutulumunun Prognostik Önemi. Cerrahpaşa Tıp Dergisi. 2013;40:45–52.
MLA
Duraker, Nüvit. “Mide Karsinomalı Hastalarda Mikroskopik Rezeksiyon Sınırı Tutulumunun Prognostik Önemi”. Cerrahpaşa Tıp Dergisi, vol. 40, no. 2, 2013, pp. 45-52.
Vancouver
Duraker N. Mide Karsinomalı Hastalarda Mikroskopik Rezeksiyon Sınırı Tutulumunun Prognostik Önemi. Cerrahpaşa Tıp Dergisi. 2013;40(2):45-52.